-
Atypical Cases Of Diabetic Ketoacidosis (DKA) Associated With Use Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors Invokana, Farxiga, And Jardiance
New Drug Safety Announcement By European Medicines Agency (EMA) Intended To Help Minimize Risk Of DKA Side Effect With This Class Of New Diabetes Drugs (Posted by Tom Lamb at DrugInjuryWatch.com) ________________________________________________________________________________ UPDATE:…
-
Xarelto Clinical Trial Issue May Lead To Dosage Level Testing For All New Oral Anticogaulant Drugs
Medical Journal Article Says FDA Might Make This Change For Patients Using Eliquis, Pradaxa, Savaysa, Or Xarelto (Posted by Tom Lamb at DrugInjuryWatch.com) UPDATE: Xarelto trial results reaffirmed despite faulty device (Reuters,…
-
New Medical Study About SSRI Antidepressants Used During Pregnancy And Autism Spectrum Disorder (ASD) In Children
JAMA Pediatrics Article Reports Increased Risk Is Greatest When These Depression Medicines Are Used By Mothers During The Second And/Or Third Trimester (Posted by Tom Lamb at DrugInjuryWatch.com) Some popular medications prescribed…
-
Eliquis, Savaysa, And Xarelto: New Blood Thinner Drugs Feared By Many Doctors Because No Antidote Is Available When Needed
Some Recent Articles Point Out the Real Problems And Consequences Of Major Bleeding Events Involving Eliquis, Savaysa, And Xarelto (Posted by Tom Lamb at DrugInjuryWatch.com) As many of you know from direct-to-consumer…
-
FDA Adds Ketoacidosis Warnings To Diabetes Drugs Invokana, Farxiga, And Jardiance As Well As Other SGLT2 Inhibitors
This Follows October 2015 Safety Alert By Health Canada Concerning Increased Risks Of Kidney Problems (Posted by Tom Lamb at DrugInjuryWatch.com) ________________________________________________________________________________ UPDATE: “Health Canada Warns About Link Between DKA & Popular Diabetes…